Werfen is a global leader in specialized diagnostics, dedicated to improving patient care through innovative solutions in In Vitro Diagnostics (IVD). With over 50 years of expertise, Werfen develops, manufactures, and distributes diagnostic systems, reagents, and data management solutions for hospitals, clinical laboratories, and healthcare professionals worldwide. The company’s portfolio focuses on three key areas: Hemostasis, Acute Care Diagnostics, and Autoimmunity. By advancing diagnostic accuracy and efficiency, Werfen empowers healthcare providers to make precise, life-saving decisions. Its solutions are used in critical care settings, including emergency rooms, intensive care units, and clinical labs. Driven by a commitment to research and development, Werfen continuously pioneers cutting-edge technologies. Its global network spans over 30 subsidiaries and a presence in more than 100 countries, ensuring world-class support and service. Werfen’s mission goes beyond diagnostics—it’s about creating a healthier future by delivering reliability, innovation, and partnership. With a steadfast focus on improving patient outcomes, Werfen remains a trusted ally to healthcare professionals navigating the complexities of modern medicine.
Australasian Association for Clinical Biochemistry and Laboratory Medicine
PO Box 7336, Alexandria NSW 2015
P: (61) 2 9669 6600 E: conference@aacb.asn.au
www.aacb.asn.au